Skip to main content
Have a personal or library account? Click to login
Engaging Social Stakeholders in National Asbestos Research for Public Health: An Italian Experience Cover

Engaging Social Stakeholders in National Asbestos Research for Public Health: An Italian Experience

Open Access
|Jun 2025

References

  1. World Health Organization (WHO). Elimination of Asbestos‑Related Diseases 2006. WHO. 2006. Accessed December 10, 2024. https://www.who.int/publications/i/item/WHO-SDE-OEH-06.03.
  2. World Health Organization (WHO). Declaration of the Sixth Ministerial Conference on Environment and Health. World Health Regional Office for Europe. 2017.
  3. Takahashi K, Landrigan PJ on behalf of the Collegium Ramazzini. The global health dimensions of asbestos and asbestos‑related diseases. Ann Glob Health. 2016;82:209213. doi:10.1016/j.aogh.2016.01.01.
  4. Furuya S, Chimed‑Ochir O, Takahashi K, David A, Takala J. Global asbestos disaster. Int J Environ Res Public Health. May 16, 2018;15(5):1000. doi:10.3390/ijerph15051000.
  5. Aryal A, Morley C. Call for a global ban policy on and scientific management of asbestos to eliminate asbestos‑related diseases. J Public Health Policy. September 2020;41(3):279285. doi:10.1057/s41271-020-00223-4.
  6. Arachi D, Furuya S, David A, et al. Development of the “National Asbestos Profile” to eliminate asbestos‑related diseases in 195 Countries. Int J Environ Res Public Health. February 12, 2021;18(4):1804. doi:10.3390/ijerph18041804.
  7. Gariazzo C, Gasparrini A, Marinaccio A. Asbestos consumption and malignant mesothelioma mortality trends in the major user Countries. Ann Glob Health. February 13, 2023;89(1):11. doi:10.5334/aogh.4012.
  8. IARC. Arsenic, metals, fibres, and dusts. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC Monogr Eval Carcinog Risks Hum. 2012;100(Pt C):11465. Accessed December 10, 2024. https://publications.iarc.fr/Book-And-Report-Series/Iarc-Monographs-On-The-Identification-Of-Carcinogenic-Hazards-To-Humans/Arsenic-Metals-Fibres-And-Dusts-2012.
  9. IARC. Fluoro‑edenite. In: IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, International Agency for Research on Cancer, ed. Some Nanomaterials and Some Fibres. International Agency for Research on Cancer; 2017:215242. Accessed December 10, 2024. https://publications.iarc.fr/Book-And-Report-Series/Iarc-MonographsOn-The-Identification-Of-Carcinogenic-Hazards-To-Humans/Some-Nanomaterials-And-Some-Fibres-2017.
  10. Thieves LP, Ghisi E, Thives Júnior JJ, Vieira AS. Is asbestos still a problem in the world? A current review. J Environ Manage. October 1, 2022;319:115716. doi:10.1016/j.jenvman.2022.115716.
  11. Marsili D, Angelini A, Bruno C, et al. Asbestos Ban in Italy: A major milestone, not the final cut. Int J Environ Res Public Health. November 13, 2017a;14(11):1379. doi:10.3390/ijerph14111379.
  12. Fazzo L, Minelli G, De Santis M, Ceccarelli E, Iavarone I, Zona A. The Epidemiological surveillance of mesothelioma mortality in Italy as a tool for the prevention of asbestos exposure. Int J Environ Res Public Health. May 25, 2023;20(11):5957. doi:10.3390/ijerph20115957.
  13. Han Y, Zhang T, Chen H, Yang X. Global magnitude and temporal trend of mesothelioma burden along with the contribution of occupational asbestos exposure in 204 countries and territories from 1990 to 2019: Results from the Global Burden of Disease Study 2019. Crit Rev Oncol Hematol. November 2022;179:103821. doi:10.1016/j.critrevonc.2022.103821.
  14. Magnani C, Silvestri S, Angelini A, et al. Italian pool of asbestos workers cohorts: Asbestos related mortality by industrial sector and cumulative exposure. Ann Ist Super Sanita. July‑September 2020;56(3):292302. doi:10.4415/ANN_20_03_07.
  15. International Labour Office and World Health Organization. Outline for the Development of National Programs for Elimination of Asbestos Related Diseases. 2007. Accessed December 10, 2024. https://www.ilo.org/safework/info/publications/WCMS_108555/lang--en/index.htm.
  16. Inail, Italian national mesothelioma registry. Registro Nazionale dei Mesoteliomi: Ottavo rapport. 2025. Accessed May 12, 2025. https://www.inail.it/portale/it/inail-comunica/pubblicazioni/catalogo-generale/catalogo-generale-dettaglio.2025.02.registro-nazionale-dei-mesoteliomi--ottavo-rapporto.html.
  17. Donelli G, Marsili D, Comba P. Abestos‑Related Scientific and Health Issues: Activities of the Istituto Superiore di Sanità in the Years 1980–2012. Istituto Superiore di Sanità; 2012. (I Beni Storico‑Scientifici Dell’istituto Superiore di Sanità 9). [Italian]. Accessed December 10, 2024. http://www.iss.it/binary/pres/cont/libro_amianto.pdf.
  18. Zona A, Fazzo L, Binazzi A, et al. SENTIERI‑ReNaM: Discussion and concluding remarks [Italian]. Epidemiol Prev. September‑October 2016;40(5 Suppl1):105108.
  19. Fazzo L, De Santis M, Minelli G, Zona A. eds. Impact of Asbestos on Mortality. Italy, 2010–2020. Istituto Superiore di Sanità; 2024:iii, 84. Rapporti ISTISAN 24/18 (Italian). Accessed December 10, 2024. https://www.iss.it/documents/20126/9340227/24-18+web.pdf/80c828b5-dba8-91f1-c70f-a221e1ea6e0b?t=1729086293853.
  20. Manna P, Comba P. Communicating with health authorities and the public about asbestos risk in Biancavilla (CT) [Italian]. Epidemiol Prev. January‑February 2001;25(1):2830.
  21. Bruno C, Marsili D, Bruni BM, Comba P, Scondotto S. Preventing fluoro‑edenite related disease: The Biancavilla model. Research, public health and health promotion interventions [Italian]. Not Ist Super Sanità. 2015;28(5):319. Accessed December10, 2024. https://www.iss.it/documents/20126/45616/ONLINEBiancavilla.pdf/9e93d72a-9fd6-569a-f6f8-3c86353610bb?t=1581097428228.
  22. Comba P, Bruno C, Marsili D. Partnership between scientists and populations resident in contaminated sites. The Case study of Biancavilla, Italy. Eur J Oncol Environ Health. 2024;29(1):15384. Accessed December 10, 2024. https://mattioli1885journals.com/index.php/EJOEH/article/view/15384.
  23. Marsili D, Magnani C, Canepa A, et al. Communication and health education in communities experiencing asbestos risk and health impacts in Italy. Ann Ist Super Sanita. January‑March 2019a;55(1):7079. doi:10.4415/ANN_19_01_14.
  24. Marsili D, Canepa A, Mossone N, Comba P. Environmental health education for asbestos‑contaminated communities in Italy: The Casale Monferrato case study. Ann Glob Health. June 17, 2019b;85(1):84. doi:10.5334/aogh.2491.
  25. Bonafede M, Granieri A, Binazzi A, et al. Psychological distress after a diagnosis of malignant mesothelioma in a group of patients and caregivers at the national priority contaminated site of Casale Monferrato. Int J Environ Res Public Health. June 17, 2020;17(12):4353. doi:10.3390/ijerph17124353.
  26. Ziglioli B. Sembrava nevicasse. La Eternit di Casale Monferrato e la Fibronit di Broni: Due comunità di fronte all’amianto. Franco Angeli; 2016:101137. ISBN: 9788891750235.
  27. Marinaccio A, Binazzi A, Minelli G, Mensi C, Gruppo di lavoro del progetto SEPRA. Progetto INAIL “Sorveglianza Epidemiologica, Prevenzione e Ricerca su Amianto” (SEPRA). In: Fazzo L, De Santis M, Minelli G, Zona A, eds. Impact of asbestos on mortality. Italy, 2010–2020. Istituto Superiore di Sanità; 2024; iii, 84. Rapporti ISTISAN 24/18 [Italian]. Accessed December 10, 2024. https://www.iss.it/documents/20126/9340227/24-18+web.pdf/80c828b5-dba8-91f1-c70f-a221e1ea6e0b?t=1729086293853.
  28. Concannon TW, Meissner P, Grunbaum JA, et al. A new taxonomy for stakeholder engagement in patient‑centered outcomes research. J Gen Intern Med. 2012;27(8):985989.
  29. Vincenten J, George F, Martuzzi M, Schröder‑Bäck P, Paunovic E. Barriers and facilitators to the elimination of asbestos related diseases‑Stakeholders’ perspectives. Int J Environ Res Public Health. October 22, 2017;14(10):1269. doi:10.3390/ijerph14101269.
  30. Marcu A, McGregor F, Egan B, Hill K, Cook T, Arber A. Developing sustainable patient and public involvement in mesothelioma research: Multi‑method exploration with researchers, patients, carers, and patient organisations. Res Involv Engagem. March 25, 2023;9(1):15. doi:10.1186/s40900-023-00426-5.
  31. Petkovic J, Magwood O, Lytvyn L, et al. Key issues for stakeholder engagement in the development of health and healthcare guidelines. Res Involv Engagem. 2023;9:27. doi:10.1186/s40900-023-00433-6.
  32. Marsili D, Fazzo L, Iavarone I, Comba P. Communication plans in contaminated areas as prevention tools for informed policy. Public Health Panorama. 2017b;3(2):261267. Accessed December 10, 2024. http://www.euro.who.int/en/publications/public-health-panorama/journal-issues/volume-3,issue-2,june-2017/policy-and-practice2.
  33. Marsili D, Pasetto R, Iavarone I. Environmental public health communication to engage stakeholders and foster social capacity in poorly involved communities living in industrial contaminated sites: The case study of Porto Torres (Italy). Front Commun. 2023;8:1217427. doi:10.3389/fcomm.2023.1217427.
  34. Stoppa G, Mensi C, Fazzo L, et al. Malattie amianto correlate: il caso studio del tumore dell’ovaio in Lombardia. Rapporto ISTISAN 24/18. In: Fazzo L, De Santis M, Minelli G, Zona A, eds. Impact of Asbestos on Mortality. Italy, 2010–2020. Istituto Superiore di Sanità; 2024a: iii, 84, 7784. Rapporti ISTISAN 24/18 [Italian]. Accessed December 10, 2024. https://www.iss.it/documents/20126/9340227/24-18+web.pdf/80c828b5-dba8-91f1-c70f-a221e1ea6e0b?t=1729086293853.
  35. Granieri A. Extreme trauma in a polluted area: Bonds and relational transformations in an Italian community. Int Forum Psychoanal. 2016;25(2):94103.
  36. Granieri A, Borgogno FV, Franzoi IG, Gonella M, Guglielmucci F. Development of a Brief Psychoanalytic Group Therapy (BPG) and its application in an asbestos National Priority Contaminated Site. Ann Ist Super Sanità. 2018;54(2):161167. doi:10.4415/ANN_18_02_12.
  37. Stoppa G, Mensi C, Fazzo L, et al. Ovarian cancer deaths attributable to asbestos exposure in Lombardy (Italy) in 2000–2018. Occup Environ Med. 2024b;81(7):359365.
  38. Merler E, Marinaccio A. Istituito un fondo nazionale per le vittime dell’amianto [An Italian fund for the asbestos victims]. Epidemiol Prev. January‑February 2008;32(1):1617. Italian. PMID: 18488948.
  39. Bertolotti M, Tambubrro M, Salzo A, et al. Knowledge and awareness of asbestos risk among General Practitioners: Validation of a questionnaire in an area with a high incidence of asbestos‑related diseases. Prev Med Rep. 2025;49:102940. doi:10.1016/j.pmedr.2024.102940.
  40. Marinaccio A, Gariazzo C, Di Marzio D, Iavicoli S, ReNaM Working Group. Predictors of filing claims and receiving compensation in malignant mesothelioma patients. Health Policy. September 2020;124(9):10321040. doi:10.1016/j.healthpol.2020.06.005.
  41. Cottrell EK, Whitlock EP, Kato E, et al. Defining the benefits and challenges of stakeholder engagement in systematic reviews. Comp Eff Res. 2015;5:1319. doi:10.2147/CER.S69605.
DOI: https://doi.org/10.5334/aogh.4717 | Journal eISSN: 2214-9996
Language: English
Submitted on: Feb 17, 2025
Accepted on: May 19, 2025
Published on: Jun 5, 2025
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2025 Daniela Marsili, Alessandra Binazzi, Alessandro Marinaccio, Carolina Mensi, Lucia Fazzo, SEPRA project Working Group for the study on communication and social stakeholders’ engagement, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.